methylprednisolone hemisuccinate has been researched along with Anterior Optic Neuritis in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (36.36) | 18.2507 |
2000's | 5 (45.45) | 29.6817 |
2010's | 2 (18.18) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bowman, D; Day, C; Fraser, JA; Kremenchutzky, M; Morrow, SA; Nicolle, M; Rosehart, H | 1 |
Dai, Y; Gong, Y; Jiang, Z; Li, H; Liu, Z; Wei, S; Zhang, Y | 1 |
Kodama, T; Masuda, H; Nonoyama, S; Ohira, A; Shibuya, Y | 1 |
Beck, RW; Bhatti, MT; Brodsky, MC; Buckley, EG; Chrousos, GA; Corbett, J; Eggenberger, E; Gal, RL; Goodwin, JA; Katz, B; Kaufman, DI; Keltner, JL; Kupersmith, MJ; Miller, NR; Moke, PS; Nazarian, S; Orengo-Nania, S; Savino, PJ; Shults, WT; Smith, CH; Trobe, JD; Wall, M; Xing, D | 1 |
Kaliciak-Kempińska, A; Mazur-Chłodek, L | 1 |
Chung, JH; Frohman, LP; Turbin, RE; Van Stavern, GP | 1 |
Brass, SD; Cestari, DM; Dinkin, MJ; Lessell, S; Stein, MC | 1 |
Backlund, JC; Beck, RW; Bourque, LB; Cleary, PA; Miskala, PH | 1 |
Beck, RW; Trobe, JD | 1 |
Catalano, RA; Litoff, D | 1 |
5 trial(s) available for methylprednisolone hemisuccinate and Anterior Optic Neuritis
Article | Year |
---|---|
Effect of Treating Acute Optic Neuritis With Bioequivalent Oral vs Intravenous Corticosteroids: A Randomized Clinical Trial.
Topics: Acute Disease; Administration, Intravenous; Administration, Oral; Adrenal Cortex Hormones; Adult; Evoked Potentials, Visual; Female; Humans; Male; Methylprednisolone Hemisuccinate; Middle Aged; Optic Neuritis; Prednisone; Single-Blind Method; Therapeutic Equivalency; Treatment Outcome | 2018 |
High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial.
Topics: Acute Disease; Adolescent; Adult; Anti-Inflammatory Agents; Brain; Cohort Studies; Female; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone Hemisuccinate; Middle Aged; Multiple Sclerosis; Optic Neuritis; Prednisone; Prospective Studies; Risk Factors; Sex Factors; United States | 2003 |
Visual symptoms after optic neuritis. Results from the Optic Neuritis Treatment Trial.
Topics: Adult; Female; Follow-Up Studies; Glucocorticoids; Humans; Male; Methylprednisolone Hemisuccinate; Optic Neuritis; Prednisone; Quality of Life; Retrospective Studies; Self Disclosure; Surveys and Questionnaires; Vision Disorders; Vision, Ocular | 1997 |
What we have learned from the Optic Neuritis Treatment Trial.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Anti-Inflammatory Agents; Brain; Female; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Methylprednisolone Hemisuccinate; Middle Aged; Multiple Sclerosis; Optic Neuritis; Prednisolone; Treatment Outcome; Visual Acuity | 1995 |
Visual function 5 years after optic neuritis: experience of the Optic Neuritis Treatment Trial. The Optic Neuritis Study Group.
Topics: Administration, Oral; Adolescent; Adult; Cohort Studies; Color Perception; Contrast Sensitivity; Female; Follow-Up Studies; Glucocorticoids; Humans; Incidence; Injections, Intravenous; Male; Methylprednisolone Hemisuccinate; Middle Aged; Multiple Sclerosis; Optic Neuritis; Prednisone; Recurrence; Visual Acuity; Visual Fields | 1997 |
6 other study(ies) available for methylprednisolone hemisuccinate and Anterior Optic Neuritis
Article | Year |
---|---|
Application of immunosuppressant facilitates the therapy of optic neuritis combined with Sjögren's syndrome.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Female; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methylprednisolone Hemisuccinate; Middle Aged; Optic Neuritis; Sjogren's Syndrome; Visual Acuity; Young Adult | 2014 |
Recovery of vision after chiasmal optic neuritis.
Topics: Adult; Female; Glucocorticoids; Humans; Magnetic Resonance Imaging; Methylprednisolone Hemisuccinate; Optic Chiasm; Optic Neuritis; Recovery of Function; Visual Acuity; Visual Field Tests; Visual Fields | 2003 |
[Side effects during treatment with Solu-Medrol for optic neuritis in the course of MS].
Topics: Adult; Female; Headache; Humans; Leukocyte Disorders; Methylprednisolone Hemisuccinate; Multiple Sclerosis; Nausea; Neuroprotective Agents; Optic Neuritis | 2003 |
Adalimumab-associated optic neuritis.
Topics: Adalimumab; Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Arthritis, Rheumatoid; Humans; Immunity, Cellular; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methylprednisolone Hemisuccinate; Middle Aged; Optic Nerve; Optic Neuritis; Treatment Outcome; Tumor Necrosis Factor-alpha; Vision, Low | 2006 |
NMO antibody-positive recurrent optic neuritis without clear evidence of transverse myelitis.
Topics: Adult; Aquaporin 4; Autoantibodies; Autoantigens; Brain; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunoglobulin G; Infusions, Intravenous; Magnetic Resonance Imaging; Methylprednisolone Hemisuccinate; Myelitis, Transverse; Optic Neuritis; Recurrence | 2008 |
Herpes zoster optic neuritis in human immunodeficiency virus infection.
Topics: Acyclovir; Adult; Female; Herpes Zoster Ophthalmicus; HIV Seropositivity; Humans; Injections, Intravenous; Methylprednisolone Hemisuccinate; Optic Neuritis; Tomography, X-Ray Computed | 1990 |